|
|
|
| Clinical Efficacy of Tislelizumab Combined with First-line Chemotherapy in the Treatment of Advanced Esophageal Cancer Patients and Its Impact on Serum Tumor Markers |
| CHENG Meiying, WANG Xin, ZHOU Yongjing, XIE Yanyan, WANG Yali |
| First-author's address: Department of Oncology, Zhenjiang First People's Hospital, Zhenjiang 212000, China |
|
|
|
|
|
|
Received: 02 November 2023
|
|
|
|
|
|
|
